Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use combined 5-HT1A agonists and selective serotonin reuptake inhibitors

US Patent 7479492 · Granted Jan 20, 2009

Estimated economic value: $102,907,000

Assignee

Inventors

View full patent text on Google Patents →